{
    "startDate": "2017-01-01",
    "endDate": "2017-09-30",
    "year": "2017",
    "quarter": "Q3",
    "symbol": "VKTX",
    "data": {
        "bs": [
            {
                "label": "Cash and cash equivalents",
                "concept": "CashAndCashEquivalentsAtCarryingValue",
                "unit": "usd",
                "value": 2568063
            },
            {
                "label": "Short-term investments \u2013 available for sale",
                "concept": "AvailableForSaleSecuritiesCurrent",
                "unit": "usd",
                "value": 7270719
            },
            {
                "label": "Prepaid clinical trial costs.",
                "concept": "vktx:PrepaidClinicalTrialCosts",
                "unit": "usd",
                "value": 1346171
            },
            {
                "label": "Prepaid expenses and other current assets",
                "concept": "PrepaidExpenseAndOtherAssetsCurrent",
                "unit": "usd",
                "value": 340121
            },
            {
                "label": "Current assets:",
                "concept": "AssetsCurrent",
                "unit": "usd",
                "value": 11525074
            },
            {
                "label": "Deferred public offering and other financing costs noncurrent.",
                "concept": "vktx:DeferredPublicOfferingAndOtherFinancingCostsNoncurrent",
                "unit": "usd",
                "value": 275029
            },
            {
                "label": "Deposits",
                "concept": "DepositsAssetsNoncurrent",
                "unit": "usd",
                "value": 39341
            },
            {
                "label": "Assets",
                "concept": "Assets",
                "unit": "usd",
                "value": 11839444
            },
            {
                "label": "Accounts payable",
                "concept": "AccountsPayableCurrent",
                "unit": "usd",
                "value": 1555472
            },
            {
                "label": "Other accrued liabilities",
                "concept": "OtherAccruedLiabilitiesCurrent",
                "unit": "usd",
                "value": 2837392
            },
            {
                "label": "Accrued interest, current",
                "concept": "InterestPayableCurrent",
                "unit": "usd",
                "value": 9982
            },
            {
                "label": "Convertible notes payable, current (net of discount of $662,588 and $675,589 at September 30, 2017 and December 31, 2016, respectively)",
                "concept": "ConvertibleNotesPayableCurrent",
                "unit": "usd",
                "value": 3180411
            },
            {
                "label": "Debt conversion feature liability current.",
                "concept": "vktx:DebtConversionFeatureLiabilityCurrent",
                "unit": "usd",
                "value": 2030226
            },
            {
                "label": "Current liabilities:",
                "concept": "LiabilitiesCurrent",
                "unit": "usd",
                "value": 9613483
            },
            {
                "label": "Liabilities and stockholders\u2019 equity",
                "concept": "Liabilities",
                "unit": "usd",
                "value": 9613483
            },
            {
                "label": "Commitments and contingencies (Note 8)",
                "concept": "CommitmentsAndContingencies",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Preferred stock, $0.00001 par value: 10,000,000 shares authorized at September 30, 2017 and December 31, 2016; no shares issued and outstanding at September 30, 2017 and December 31, 2016",
                "concept": "PreferredStockValue",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Common stock, $0.00001 par value: 300,000,000 shares authorized at September 30, 2017 and December 31, 2016; 28,498,847 and 20,823,873 shares issued and outstanding at September 30, 2017 and December 31, 2016, respectively",
                "concept": "CommonStockValue",
                "unit": "usd",
                "value": 285
            },
            {
                "label": "Additional paid-in capital",
                "concept": "AdditionalPaidInCapitalCommonStock",
                "unit": "usd",
                "value": 78999693
            },
            {
                "label": "Accumulated deficit",
                "concept": "RetainedEarningsAccumulatedDeficit",
                "unit": "usd",
                "value": -76770459
            },
            {
                "label": "Accumulated other comprehensive loss",
                "concept": "AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax",
                "unit": "usd",
                "value": -3558
            },
            {
                "label": "Stockholders\u2019 equity:",
                "concept": "StockholdersEquity",
                "unit": "usd",
                "value": 2225961
            },
            {
                "label": "Liabilities and stockholders\u2019 equity",
                "concept": "LiabilitiesAndStockholdersEquity",
                "unit": "usd",
                "value": 11839444
            }
        ],
        "cf": [
            {
                "label": "Net loss",
                "concept": "NetIncomeLoss",
                "unit": "usd",
                "value": -16493192
            },
            {
                "label": "Amortization of debt discount",
                "concept": "AmortizationOfDebtDiscountPremium",
                "unit": "usd",
                "value": 1024479
            },
            {
                "label": "Amortization of investment premiums",
                "concept": "InvestmentIncomeAmortizationOfPremium",
                "unit": "usd",
                "value": 78683
            },
            {
                "label": "Amortization of financing costs equity transactions.",
                "concept": "vktx:AmortizationOfFinancingCostsEquityTransactions",
                "unit": "usd",
                "value": 537528
            },
            {
                "label": "Amortization of non cash clinical trial costs.",
                "concept": "vktx:AmortizationOfNonCashClinicalTrialCosts",
                "unit": "usd",
                "value": 648481
            },
            {
                "label": "Change In fair value of debt conversion features.",
                "concept": "vktx:ChangeInFairValueOfDebtConversionFeatures",
                "unit": "usd",
                "value": -287700
            },
            {
                "label": "Stock-based compensation",
                "concept": "ShareBasedCompensation",
                "unit": "usd",
                "value": 1087625
            },
            {
                "label": "Prepaid expenses and other current assets",
                "concept": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets",
                "unit": "usd",
                "value": -299362
            },
            {
                "label": "Accounts payable",
                "concept": "IncreaseDecreaseInAccountsPayable",
                "unit": "usd",
                "value": 232124
            },
            {
                "label": "Accrued expenses",
                "concept": "IncreaseDecreaseInAccruedLiabilities",
                "unit": "usd",
                "value": 1487445
            },
            {
                "label": "Cash flows from operating activities",
                "concept": "NetCashProvidedByUsedInOperatingActivitiesContinuingOperations",
                "unit": "usd",
                "value": -10809765
            },
            {
                "label": "Purchases of investments",
                "concept": "PaymentsToAcquireInvestments",
                "unit": "usd",
                "value": 13106231
            },
            {
                "label": "Proceeds from maturities of investments",
                "concept": "ProceedsFromSaleMaturityAndCollectionsOfInvestments",
                "unit": "usd",
                "value": 15772000
            },
            {
                "label": "Cash flows from investing activities",
                "concept": "NetCashProvidedByUsedInInvestingActivitiesContinuingOperations",
                "unit": "usd",
                "value": 2665769
            },
            {
                "label": "Proceeds from issuances of common stock, net of underwriting discounts and commissions",
                "concept": "ProceedsFromIssuanceOfCommonStock",
                "unit": "usd",
                "value": 7832278
            },
            {
                "label": "Public offering and financing costs",
                "concept": "PaymentsOfStockIssuanceCosts",
                "unit": "usd",
                "value": 123985
            },
            {
                "label": "Repayment of convertible notes payable",
                "concept": "RepaymentsOfConvertibleDebt",
                "unit": "usd",
                "value": 77261
            },
            {
                "label": "Value of shares withheld related to employee tax withholding",
                "concept": "PaymentsRelatedToTaxWithholdingForShareBasedCompensation",
                "unit": "usd",
                "value": 14084
            },
            {
                "label": "Proceeds from stock issuance under employee stock purchase plan",
                "concept": "ProceedsFromStockPlans",
                "unit": "usd",
                "value": 19609
            },
            {
                "label": "Cash flows from financing activities",
                "concept": "NetCashProvidedByUsedInFinancingActivitiesContinuingOperations",
                "unit": "usd",
                "value": 7636557
            },
            {
                "label": "Net increase (decrease) in cash and cash equivalents",
                "concept": "CashAndCashEquivalentsPeriodIncreaseDecrease",
                "unit": "usd",
                "value": -507439
            },
            {
                "label": "Cash paid during the period for interest",
                "concept": "InterestPaid",
                "unit": "usd",
                "value": 122739
            },
            {
                "label": "Shares issued",
                "concept": "StockIssued1",
                "unit": "usd",
                "value": 1800000
            },
            {
                "label": "Unpaid deferred initial public offering and financing costs.",
                "concept": "vktx:UnpaidDeferredInitialPublicOfferingAndOtherFinancingCosts",
                "unit": "usd",
                "value": 219509
            }
        ],
        "ic": [
            {
                "label": "Revenues",
                "concept": "Revenues",
                "unit": "usd",
                "value": 0
            },
            {
                "label": "Research and development",
                "concept": "ResearchAndDevelopmentExpense",
                "unit": "usd",
                "value": 10708169
            },
            {
                "label": "General and administrative",
                "concept": "GeneralAndAdministrativeExpense",
                "unit": "usd",
                "value": 3934768
            },
            {
                "label": "Operating expenses:",
                "concept": "OperatingExpenses",
                "unit": "usd",
                "value": 14642937
            },
            {
                "label": "Loss from operations",
                "concept": "OperatingIncomeLoss",
                "unit": "usd",
                "value": -14642937
            },
            {
                "label": "Change In fair value of debt conversion features.",
                "concept": "vktx:ChangeInFairValueOfDebtConversionFeatures",
                "unit": "usd",
                "value": -287700
            },
            {
                "label": "Amortization of debt discount",
                "concept": "AmortizationOfDebtDiscountPremium",
                "unit": "usd",
                "value": 1024479
            },
            {
                "label": "Amortization of financing costs equity transactions.",
                "concept": "vktx:AmortizationOfFinancingCostsEquityTransactions",
                "unit": "usd",
                "value": 537528
            },
            {
                "label": "Interest income (expense), net",
                "concept": "InterestIncomeExpenseNonoperatingNet",
                "unit": "usd",
                "value": -548
            },
            {
                "label": "Other income (expense):",
                "concept": "OtherNonoperatingIncomeExpense",
                "unit": "usd",
                "value": -1850255
            },
            {
                "label": "Net loss",
                "concept": "NetIncomeLoss",
                "unit": "usd",
                "value": -16493192
            },
            {
                "label": "Unrealized gain on securities",
                "concept": "OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax",
                "unit": "usd",
                "value": 3334
            },
            {
                "label": "Comprehensive loss",
                "concept": "ComprehensiveIncomeNetOfTax",
                "unit": "usd",
                "value": -16489858
            },
            {
                "label": "Basic and diluted net loss per share",
                "concept": "EarningsPerShareBasicAndDiluted",
                "unit": "usd/shares",
                "value": -0.67
            },
            {
                "label": "Weighted-average shares used to compute basic and diluted net loss per share",
                "concept": "WeightedAverageNumberOfShareOutstandingBasicAndDiluted",
                "unit": "shares",
                "value": 24665941
            }
        ]
    }
}